Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sex- and Age-Dependent Outcomes of Cryoablation in Atrial Fibrillation: A 3- and 6-Month Post-Procedural QoL Analysis.

Journal of arrhythmia·2026
Same author

Mast Cells and Cardiovascular Disorders.

Current vascular pharmacology·2026
Same author

Occupational and Environment-Related Cardiovascular Disease: A Comprehensive Review of the Literature.

Current vascular pharmacology·2026
Same author

The Kallikrein-Kinin System and Cardiovascular Diseases: A Narrative Review.

Angiology·2026
Same author

The Use of Colchicine in Cardiovascular Disease: Anti-Inflammatory Mechanisms and Clinical Utility.

Current vascular pharmacology·2026
Same author

Periodontal Disease and Cardiovascular Risk Factors.

Current vascular pharmacology·2026
Same journal

Beta-Blockers Versus Flecainide for Atrial Fibrillation: A First-Line Strategy Review of Efficacy, Safety, and Patient Selection.

Cardiology in review·2026
Same journal

Cerebrovascular Disease in Pregnancy: Epidemiology, Pathophysiology, Risk Factors, Diagnostic and Management Considerations, Long-Term Maternal Outcomes: A Narrative Review.

Cardiology in review·2026
Same journal

Immunometabolism in Cardiovascular Disease: Linking Metabolic Reprogramming to Inflammation, Atherothrombosis, and Clinical Outcomes.

Cardiology in review·2026
Same journal

Cardiotoxicity of Antibody-Drug Conjugates in HER2-Positive Cancer: Beyond Left Ventricular Ejection Fraction Decline.

Cardiology in review·2026
Same journal

Celiac Disease and Cardiovascular Disease: Epidemiology, Mechanisms, and Clinical Challenges.

Cardiology in review·2026
Same journal

Valve-Specific Comparative Effectiveness of Direct Oral Anticoagulants Versus Vitamin K Antagonists After Surgical Valve Procedures in Atrial Fibrillation: A Systematic Review and Meta-Analysis.

Cardiology in review·2026
See all related articles

Related Experiment Video

Updated: Jun 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Chocolate and Cardiovascular Disease.

Antonis A Manolis1, Theodora A Manolis2, Apostolos Vouliotis3

  • 1From the Department of Medicine, Elpis General Hospital, Athens, Greece.

Cardiology in Review
|June 16, 2026
PubMed
Summary
This summary is machine-generated.

Moderate dark chocolate intake may help reduce cardiometabolic and cardiovascular risks. Its bioactive compounds offer antioxidant and anti-inflammatory benefits, supporting heart health and gut microbiota diversity.

Keywords:
cardiovascular healthchocolatecholesteroldiabetespolyphenols

Related Experiment Videos

Last Updated: Jun 17, 2026

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

Area of Science:

  • Nutritional Science
  • Cardiovascular Health
  • Food Science

Background:

  • Dark chocolate is rich in bioactive compounds like cocoa flavonoids, polyphenols, and alkaloids.
  • These compounds possess antioxidant properties, potentially benefiting cardiovascular health.
  • Phytosterol enrichment may further enhance cholesterol-lowering effects.

Purpose of the Study:

  • To explore the potential of moderate dark chocolate consumption as an adjunct strategy for reducing cardiometabolic and cardiovascular risks.
  • To investigate the physiological effects of dark chocolate, including blood pressure regulation, insulin sensitivity, and lipid metabolism.
  • To assess the impact of dark chocolate on oxidative stress, inflammation, cognitive function, and gut microbiota.

Main Methods:

  • Review of existing scientific literature and data on dark chocolate consumption and its health effects.
  • Analysis of the bioactive compounds in dark chocolate and their proposed mechanisms of action.
  • Consideration of phytosterol enrichment for enhanced cardiovascular benefits.

Main Results:

  • Moderate dark chocolate consumption is associated with potential benefits for blood pressure, insulin levels, vascular function, and glucose homeostasis.
  • Antioxidant and anti-inflammatory effects may reduce the risk of cardiovascular disease and mortality.
  • Potential improvements in cognitive function and gut microbiota diversity were observed.

Conclusions:

  • Dark chocolate, consumed in moderation, may be a valuable component of a cardiovascular-healthy diet.
  • Enrichment with phytosterols offers a palatable approach to cholesterol management.
  • Further translational and epidemiological studies are required to confirm findings and establish dietary guidelines.